News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,155 Results
Type
Article (87324)
Company Profile (759)
Press Release (771046)
Multimedia
Podcasts (166)
Webinars (27)
Section
Business (233011)
Career Advice (4137)
Deals (39784)
Drug Delivery (133)
Drug Development (91227)
Employer Resources (202)
FDA (18264)
Job Trends (17392)
News (397285)
Policy (39913)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (139)
Alzheimer's disease (1663)
Antibody-drug conjugate (ADC) (215)
Approvals (18270)
Artificial intelligence (467)
Autoimmune disease (54)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (156)
Biotechnology (484)
Bladder cancer (121)
Brain cancer (47)
Breast cancer (458)
Cancer (3663)
Cardiovascular disease (323)
Career advice (3552)
Career pathing (36)
CAR-T (236)
CDC (52)
Cell therapy (644)
Cervical cancer (32)
Clinical research (75111)
Collaboration (1321)
Company closure (4)
Compensation (879)
Complete response letters (57)
COVID-19 (2946)
CRISPR (80)
C-suite (528)
Cystic fibrosis (131)
Data (4009)
Decentralized trials (2)
Denatured (59)
Depression (106)
Diabetes (439)
Diagnostics (7069)
Digital health (32)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (173)
Drug shortages (36)
Duchenne muscular dystrophy (190)
Earnings (98671)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132565)
Executive appointments (964)
FDA (20586)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (12)
Funding (1178)
Gene editing (167)
Generative AI (45)
Gene therapy (511)
GLP-1 (1007)
Government (5363)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (35)
IgA nephropathy (55)
Immunology and inflammation (234)
Immuno-oncology (19)
Indications (51)
Infectious disease (3173)
Inflammatory bowel disease (180)
Inflation Reduction Act (14)
Influenza (89)
Intellectual property (176)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (73)
Layoffs (632)
Leadership (32)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (522)
Lymphoma (252)
Machine learning (26)
Management (66)
Manufacturing (600)
MASH (127)
Medical device (14847)
Medtech (14865)
Mergers & acquisitions (22699)
Metabolic disorders (1116)
Multiple sclerosis (132)
NASH (23)
Neurodegenerative disease (201)
Neuropsychiatric disorders (55)
Neuroscience (2623)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (55)
Obesity (550)
Opinion (307)
Ovarian cancer (122)
Pain (158)
Pancreatic cancer (159)
Parkinson's disease (224)
Partnered (28)
Patents (397)
Patient recruitment (283)
Peanut (57)
People (66123)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23152)
Phase II (32621)
Phase III (24545)
Pipeline (2565)
Policy (287)
Postmarket research (3554)
Preclinical (10452)
Press Release (72)
Prostate cancer (186)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (631)
Real estate (7418)
Recruiting (78)
Regulatory (27830)
Reports (64)
Research institute (2680)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (69)
Schizophrenia (123)
Series A (196)
Series B (145)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (97)
Tariffs (86)
The Weekly (105)
Vaccines (1021)
Venture capital (66)
Weight loss (384)
Women's health (57)
Worklife (21)
Date
Today (43)
Last 7 days (516)
Last 30 days (2424)
Last 365 days (33715)
2025 (24694)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50861)
Australia (8933)
California (9095)
Canada (2772)
China (861)
Colorado (385)
Connecticut (406)
Delaware (251)
Europe (116840)
Florida (1336)
Georgia (307)
Hawaii (3)
Idaho (67)
Illinois (797)
India (47)
Indiana (446)
Iowa (19)
Japan (291)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1233)
Massachusetts (6835)
Michigan (303)
Minnesota (550)
Mississippi (4)
Missouri (114)
Montana (33)
Nebraska (26)
Nevada (105)
New Hampshire (76)
New Jersey (2521)
New Mexico (32)
New York (2482)
North Carolina (1378)
North Dakota (10)
Northern California (4059)
Ohio (285)
Oklahoma (19)
Oregon (50)
Pennsylvania (1893)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3474)
Tennessee (146)
Texas (1420)
United States (33712)
Utah (270)
Virginia (240)
Washington D.C. (82)
Washington State (783)
West Virginia (4)
Wisconsin (94)
Wyoming (1)
There are 859,155 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpha Cognition Inc. Announces Pricing of $35 Million Oversubscribed Public Offering of Common Shares
October 1, 2025
·
6 min read
Press Releases
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
October 1, 2025
·
7 min read
Press Releases
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 30, 2025
October 1, 2025
·
1 min read
Press Releases
Toragen, Inc. Announces $12 Million Convertible Note Financing and Expansion of Board of Directors
October 1, 2025
·
2 min read
Press Releases
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes
October 1, 2025
·
4 min read
Press Releases
Enanta Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
October 1, 2025
·
4 min read
Mergers & acquisitions
The Top Big Pharmas Have $1.2T in Stretch M&A Firepower Available
The two most historically deal-conservative Big Pharmas have the most money to play with for a major M&A transaction, according to a recent Stifel analysis.
October 1, 2025
·
6 min read
·
Annalee Armstrong
Mergers & acquisitions
Just 9.5% of Life Sciences M&A Milestones Have Been Paid Since 2008
A new analysis from SRS Acquiom puts into perspective the headline values seen when a company announces a backloaded M&A deal. Biotechs have much on the line when they agree to deals with massive potential but little upfront.
October 1, 2025
·
2 min read
·
Annalee Armstrong
Opinion
The Urgent Need To Redefine the Future of UK Biotech
As major pharmas pull away from the U.K. and the U.S. risks ceding its lead through a national brain drain, the U.K. must create a new, more robust model for innovation.
October 1, 2025
·
6 min read
·
Kerstin Papenfuss
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
Talks between pharma and successive U.K. governments have failed to deliver the market access terms that the industry wants, contributing to a pullback in investment.
October 1, 2025
·
4 min read
·
Nick Paul Taylor
1 of 85,916
Next
